Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Avanir Terminates License Agreement with Optinose for ONZETRA Xsail

americanpharmaceuticalreviewDecember 12, 2018

Tag: Avanir , Optinose , ONZETRA Xsail , migraine medication

PharmaSources Customer Service